Acute Myeloid Leukemia as a Model for Cancer Therapy

by Ravandi, Farhad
Published 2012

Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly dia...

by Mayer, Jiří, Arthur, Christopher, Delaunay, Jacques, Mazur, Grzegorz, Thomas, Xavier G, Wierzbowska, Agnieszka, Ravandi, Farhad, Berrak, Erhan, Jones, Mark, Li, Yuhan, Kantarjian, Hagop M
Published 2014

Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38- Stem-Like Cells

by Kornblau, Steven M., Qutub, Amina, Yao, Hui, York, Heather, Qiu, Yi Hua, Graber, David, Ravandi, Farhad, Cortes, Jorge, Andreeff, Michael, Zhang, Nianxiang, Coombes, Kevin R.
Published 2013

IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression

by DiNardo, Courtney D, Jabbour, Elias, Ravandi, Farhad, Takahashi, Koichi, Daver, Naval, Routbort, Mark, Patel, Keyur P, Brandt, Mark, Pierce, Sherry, Kantarjian, Hagop, Garcia-Manero, Guillermo
Published 2015

Prospective Analysis: Relative Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase in the Era of Tyrosine Kinase Inhibitors

by Sasaki, Koji, Strom, Sara S., O’Brien, Susan, Jabbour, Elias, Ravandi, Farhad, Konopleva, Marina, Borthakur, Gautam, Pemmaraju, Naveen, Daver, Naval, Jain, Preetesh, Pierce, Sherry, Kantarjian, Hagop, Cortes, Jorge E.
Published 2015

The Addition of All-Trans Retinoic Acid to Chemotherapy May Not Improve the Outcome of Patient with NPM1 Mutated Acute Myeloid Leukemia

by Nazha, Aziz, Bueso-Ramos, Carlos, Estey, Eli, Faderl, Stefan, O’Brien, Susan, Fernandez, Michael H., Nguyen, Martin, Koller, Charles, Freireich, Emil, Beran, Miloslav, Pierce, Sherry, Keating, Michael, Cortes, Jorge, Kantarjian, Hagop, Ravandi, Farhad
Published 2013

Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations

by Loghavi, Sanam, Zuo, Zhuang, Ravandi, Farhad, Kantarjian, Hagop M, Bueso-Ramos, Carlos, Zhang, Liping, Singh, Rajesh R, Patel, Keyur P, Medeiros, L Jeffrey, Stingo, Francesco, Routbort, Mark, Cortes, Jorge, Luthra, Rajyalakshmi, Khoury, Joseph D
Published 2014

Resistance Prediction in AML: Analysis of 4,601 Patients from MRC/NCRI, HOVON/SAKK, SWOG, and MD Anderson Cancer Center

by Walter, Roland B., Othus, Megan, Burnett, Alan K., Löwenberg, Bob, Kantarjian, Hagop M., Ossenkoppele, Gert J., Hills, Robert K., Ravandi, Farhad, Pabst, Thomas, Evans, Anna, Pierce, Sherry R., Vekemans, Marie-Christiane, Appelbaum, Frederick R., Estey, Elihu H.
Published 2014

REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia

by Stuart, Robert K, Cripe, Larry D, Maris, Michael B, Cooper, Maureen A, Stone, Richard M, Dakhil, Shaker R, Turturro, Francesco, Stock, Wendy, Mason, James, Shami, Paul J, Strickland, Stephen A, Costa, Luciano J, Borthakur, Gautam, Michelson, Glenn C, Fox, Judith A, Leavitt, Richard D, Ravandi, Farhad
Published 2015

Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS

by Kanagal-Shamanna, Rashmi, Luthra, Rajyalakshmi, Yin, Cameron C., Patel, Keyur P., Takahashi, Koichi, Lu, Xinyan, Lee, John, Zhao, Chong, Stingo, Francesco, Zuo, Zhuang, Routbort, Mark J., Singh, Rajesh R., Fox, Patricia, Ravandi, Farhad, Garcia-Manero, Guillermo, Medeiros, L. Jeffrey, Bueso-Ramos, Carlos E.
Published 2016